4//SEC Filing
Shah Jatin 4
Accession 0001209191-21-012968
CIK 0001503802other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:12 PM ET
Size
5.2 KB
Accession
0001209191-21-012968
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2021-02-18$14.83/sh−1,186$17,590→ 51,791 total
Footnotes (2)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 18, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001782186
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 8:12 PM ET
- Size
- 5.2 KB